Hydroxyectoine Production via Recombinant Biocatalyst
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing hydroxyectoine are inefficient, costly, and time-intensive due to the unfavorable layout of the biosynthetic pathway, resulting in low titers and high production costs, with existing approaches failing to scale up production effectively.
Innovation Solution
A method involving a recombinant bacterial host cell transformed with a promoter linked to a nucleotide sequence encoding ectoine hydroxylase (ectD) followed by a transcriptional terminator, cultivated with a carbon source and ectoine to facilitate biocatalytic conversion into hydroxyectoine, allowing for efficient secretion and production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional biosynthetic pathways are used for hydroxyectoine production, then production can be maintained at low levels, but production efficiency and titer remain low resulting in high costs and long production times
Solution Approach 1:
Instead of using the natural biosynthetic pathway from glucose to hydroxyectoine, the invention inverts the approach by using a biocatalyst to convert ectoine back into hydroxyectoine through heterologous expression of ectoine hydroxylase genes (ectABC). This reverse engineering of the metabolic pathway enables high-yield production that overcomes the limitations of traditional biosynthesis.
2Quantity of substance
If traditional production methods are used, then process simplicity is maintained, but production titer remains low requiring larger volumes and higher costs
Solution Approach 1:
The invention introduces a biocatalyst system comprising heterologously expressed ectoine hydroxylase enzymes (EctA, EctB, EctC) as intermediaries to convert ectoine into hydroxyectoine. These enzymatic mediators enable the transformation reaction that cannot occur through natural biosynthesis, achieving high titers despite the added complexity of the biocatalyst system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of hydroxyectoine at higher concentrations and shorter times, achieving productivity rates of up to 6.25 g/L/h with a 75 g/L titer, significantly improving the efficiency and cost-effectiveness of hydroxyectoine production compared to previous methods.
Implementation Method 1
cultivating the bacterial host cell under suitable conditions to allow biocatalytic conversion of ectoine into hydroxyectoine
Data Source
Figure 1a
Figure 1b
Figure 1c
AI summary
The present invention means and methods which allow the advantageous production of hydroxyectoine in a larger scale which is more efficient and less time and cost intensive. In particular the present invention provides in a first aspect a method for producing hydroxyectoine, comprising (a) providing a biocatalyst, wherein said biocatalyst is a recombinant bacterial host cell transformed with a promoter operably linked to a nucleotide sequence encoding an ectoine hydroxylase - ectD - (EC 1.14.11) followed by a transcriptional terminator, (b) providing a carbon source and ectoine, and (c) cultivating the bacterial host cell under suitable conditions to allow biocatalytic conversion of ectoine into hydroxyectoine, and thereby secreting the produced hydroxyectoine. The invention further relates to a recombinant bacterial host cell comprising a heterologous promoter operably linked to a nucleotide sequence encoding an ectoine hydroxylase - ectD - (EC 1.14.11) followed by a transcriptional terminator; the use of the recombinant bacterial host cell of the present invention for the production of hydroxyectoine; and a kit comprising a bacterial host cell of and a further bacterial host cell of the present invention for use in a method of for producing hydroxyectoine.